Want to join the conversation?
Infusion products and services provider $INFU said it has elected Scott Shuda, MD and co-founder of Meridian OHC Partners and BlueLine Partners, to serve as a new member of its BoD, effective Sept. 7, 2016. Shuda is currently Chairman of $IRIX's Compensation Committee and member of Nominating and Governance Committee.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?